|
FDA approves Spevigo for pustular psoriasis
|
Fri-14-10-2022, 16:30 PM
(Fri-14-10-2022, 15:11 PM)Fred Wrote: Update: The European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the granting of a conditional market authorization for Boehringer Ingelheim’s spesolimab as first in class treatment option for generalized pustular psoriasis (GPP) flares in adults. That is sounding good. As GPP is one of the less nice forms of psoriasis, so great if there is something that can fight it. |
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
FDA approves Spevigo for pustular psoriasis - by Fred - Sat-03-09-2022, 11:05 AM
RE: FDA approves Spevigo for pustular psoriasis - by Caroline - Sun-04-09-2022, 07:51 AM
RE: FDA approves Spevigo for pustular psoriasis - by Fred - Fri-14-10-2022, 15:11 PM
RE: FDA approves Spevigo for pustular psoriasis - by Caroline - Fri-14-10-2022, 16:30 PM
RE: FDA approves Spevigo for pustular psoriasis - by Forest Walker - Sat-15-10-2022, 13:25 PM
RE: FDA approves Spevigo for pustular psoriasis - by Fred - Sat-15-10-2022, 20:15 PM
RE: FDA approves Spevigo for pustular psoriasis - by Fred - Wed-14-12-2022, 14:29 PM
RE: FDA approves Spevigo for pustular psoriasis - by Fred - Wed-20-03-2024, 17:06 PM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
| Pustular psoriasis and mortality | Fred | 0 | 821 |
Sat-26-09-2026, 12:27 PM Last Post: Fred |
|
| EU approves Skyrizi for children with psoriasis | Fred | 2 | 1,925 |
Tue-30-06-2026, 16:51 PM Last Post: Caroline |
|
| FDA Approves Zoryve for psoriasis | Fred | 4 | 9,780 |
Tue-30-06-2026, 13:12 PM Last Post: Fred |
|
| Efficacy and safety of Imsidolimab for pustular psoriasis | Fred | 0 | 1,276 |
Wed-29-04-2026, 14:58 PM Last Post: Fred |
|
| Generalized pustular psoriasis study | Fred | 0 | 1,279 |
Tue-17-03-2026, 13:53 PM Last Post: Fred |
|
Health Boards
